lamotrigine accord 50mg tablets tablets
accord healthcare limited - lamotrigine - tablets - 50mg
rimycin 300 rifampicin 300 mg capsule bottle
alphapharm pty ltd - rifampicin, quantity: 300 mg - capsule, hard - excipient ingredients: purified talc; gelatin; purified water; ascorbic acid; magnesium stearate; brilliant blue fcf; colloidal anhydrous silica; sodium lauryl sulfate; titanium dioxide; erythrosine; lactose monohydrate - indications as at 5 december 2001 : tuberculosis. in the initial treatment and in retreatment of patients with tuberculosis, rifampicin must be used in conjunction with at least one other antituberculosis drug. leprosy - in the management of lepromatous leprosy and dimorphous leprosy to effect speedy conversion of the infectious state to the non-infectious state which may be expected to occur in three to four months of treatment. - as an alternative drug in lepromatous, dimorphous, indeterminate and tuberculoid leprosy resistant to sulfones and other anti-leprosy drugs. - as an alternative drug in all those patients having true drug allergy to the more commonly used anti-leprosy drugs.,meningococcal disease prophylaxis of meningococcal disease in close contacts of known cases and in carriers (rifampicin is not indicated for the treatment of meningococcal infections).,haemophilus influenzae prophylaxis of household contacts of patients with haemophilus influenzae type b.,buruli ulcer for the treatment of myc
rimycin 150 rifampicin 150 mg capsule bottle
alphapharm pty ltd - rifampicin, quantity: 150 mg - capsule, hard - excipient ingredients: ascorbic acid; magnesium stearate; iron oxide red; colloidal anhydrous silica; purified water; lactose monohydrate; brilliant blue fcf; purified talc; iron oxide yellow; erythrosine; gelatin; sodium lauryl sulfate; titanium dioxide - indications as at 5 december 2001 : tuberculosis. in the initial treatment and in retreatment of patients with tuberculosis, rifampicin must be used in conjunction with at least one other antituberculosis drug. leprosy - in the management of lepromatous leprosy and dimorphous leprosy to effect speedy conversion of the infectious state to the non-infectious state which may be expected to occur in three to four months of treatment. - as an alternative drug in lepromatous, dimorphous, indeterminate and tuberculoid leprosy resistant to sulfones and other anti-leprosy drugs. - as an alternative drug in all those patients having true drug allergy to the more commonly used anti-leprosy drugs.,meningococcal disease prophylaxis of meningococcal disease in close contacts of known cases and in carriers (rifampicin is not indicated for the treatment of meningococcal infections).,haemophilus influenzae prophylaxis of household contacts of patients with haemophilus influenzae type b.,buruli ulcer for the treatment of myc
mavenclad 10 mg tablets
merck serono ltd - cladribine - tablets - cladribine 10 mg - cladribine - mavenclad 10mg tablets is indicated for the treatment of adult patients with highly active relapsing multiple sclerosis (ms) as defined by clinical or imaging features
carvedilol tablets 25mg tablets
medicamen biotech ltd. - carvedilol - tablets - 25mg
rifampicin,isoniazid, pyrazinamide and ethambutol film coated tablet 150 mg/75 mg/400 mg/275 mg
macleods pharmaceuticals limited, india - rifampicin, pyrazinamide, ethambutol , isoniazid - film coated tablet - 150 mg/75 mg/400 mg/275 mg
rifampicin,isoniazid, pyrazinamide and ethambutol film coated tablet 150 mg/75 mg/400 mg/275 mg
macleods pharmaceuticals limited, india - rifampicin, pyrazinamide, ethambutol , isoniazid - film coated tablet - 150 mg/75 mg/400 mg/275 mg
akurit tablets
delta pharmaceutical holdings (pty) limited - rifampicin, isoniazid - film-coated tablets - each film coated tablet contains; rifampicin 150,0 mg; isoniazid 75,0 mg
rifadin
sanofi-aventis new zealand limited - rifampicin 450mg - tablet - 450 mg - active: rifampicin 450mg
rimactazid 300/150mg milligram coated tablets
sandoz gmbh - rifampicin isoniazid - coated tablets - 300/150mg milligram